rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OPRX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Stifel cuts OptimizeRx stock price target to $11 on revenue decline
      Nov 12Investing.comOPRX
      These Analysts Cut Their Forecasts On OptimizeRx After Q3 Results
      Nov 12BenzingaOPRX
      OptimizeRx Corp (OPRX) (Q3 2026) Earnings Call Highlights: Margin Expansion and Programmatic ...

      OptimizeRx Corp (OPRX) beat Q3 2026 estimates with 29% adjusted EBITDA margins and advancing DSP integrations, but a 17% revenue drop and reduced full-year outlook weigh on the near-term picture.

      Nov 12Yahoo FinanceOPRX
      OptimizeRx Corporation Q3 2026 Earnings Call Summary
      Nov 12Yahoo FinanceOPRX
      OptimizeRx Shares Tumble 20% After-Hours: Here's Why
      Nov 12BenzingaOPRX
      OPTIMIZERx earnings beat by $0.03, revenue topped estimates
      Nov 12Investing.comOPRX
      What OptimizeRx (OPRX) Said on Its Q3 Earnings Call
      Nov 12Yahoo FinanceOPRX
      OptimizeRx Q3 2026 Earnings Call Transcript
      Nov 11BenzingaOPRX
      OptimizeRx Corp. (OPRX) Q3 Earnings and Revenues Beat Estimates
      Nov 11Yahoo FinanceOPRX
      Earnings To Watch: OptimizeRx Corp (OPRX) Q3 2026 -- GF Value Sees 30.10% Upside
      Nov 10Yahoo FinanceOPRX
      Why OptimizeRx Bears Were Right Before A 52% Drop

      If you had read both the bullish and bearish August 2025 takes on OptimizeRx and decided to sit it out, the past year probably felt like a bullet dodged. For OptimizeRx shareholders, the loss over the past year was 51.6%, including dividends. That move now sits alongside weaker 2026 results and new product headlines. However, the real question is simpler: What early assumptions about digital health growth and data privacy risk were already on record before any of that unfolded? Narratives are...

      Nov 3Yahoo FinanceOPRX
      Citizens reiterates OptimizeRx stock rating citing digital spend expansion
      Oct 27Investing.comOPRX
      Trade Desk Integration and Programmatic Capabilities Drive OptimizeRx’s (OPRX) Q4 Catalyst
      Oct 22Yahoo FinanceOPRXTTD
      What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders
      Oct 2Yahoo FinanceOPRXTTD
      Why Is Trade Desk (TTD) Bringing Point Of Care EHR Ads Into OpenPath?

      Trade Desk (NasdaqGM:TTD) is linking with OptimizeRx to pipe point of care EHR media into its platform via OpenPath. The integration gives life sciences advertisers programmatic access to OptimizeRx's proprietary healthcare professional inventory inside The Trade Desk's system. The move expands healthcare focused media options for brands that want premium placements in clinical settings where prescribing decisions are made. The OptimizeRx OpenPath link into The Trade Desk sits against...

      Oct 1Yahoo FinanceOPRX
      B. Riley Raises Price Target on OptimizeRx to $11 From $10, Keeps Buy Rating

      OptimizeRx (OPRX) has an average rating of buy and mean price target of $12.40, according to analyst

      Sep 29Yahoo FinanceOPRX
      Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
      Sep 23Yahoo FinanceOPRX
      OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network

      The move gives life sciences advertisers a more streamlined way to bring specialized healthcare audiences into their broader digital media strategies.

      Sep 22Yahoo FinanceOPRXTTD
      OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook (NASDAQ:OPRX)
      Sep 18Seeking AlphaOPRX
      OptimizeRx appoints Troy Sarich as company advisor
      Sep 2Investing.comOPRX
      OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

      Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technologyWALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Troy Sarich as a Company advisor. Sarich

      Sep 2Yahoo FinanceOPRX

      This is the newest page. Registered accounts read further back.